Annual CFF
$6.87 M
+$6.91 M+18670.27%
31 December 2023
Summary:
Yield10 Bioscience annual cash flow from financing activities is currently $6.87 million, with the most recent change of +$6.91 million (+18670.27%) on 31 December 2023. During the last 3 years, it has fallen by -$408.00 thousand (-5.61%). YTEN annual CFF is now -94.46% below its all-time high of $124.03 million, reached on 31 December 2006.YTEN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$326.00 K
-$1.54 M-126.92%
30 June 2024
Summary:
Yield10 Bioscience quarterly cash flow from financing activities is currently -$326.00 thousand, with the most recent change of -$1.54 million (-126.92%) on 30 June 2024. Over the past year, it has dropped by -$3.42 million (-110.54%). YTEN quarterly CFF is now -100.30% below its all-time high of $108.06 million, reached on 31 December 2006.YTEN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$3.98 M
-$3.96 M-49.92%
30 June 2024
Summary:
Yield10 Bioscience TTM cash flow from financing activities is currently $3.98 million, with the most recent change of -$3.96 million (-49.92%) on 30 June 2024. Over the past year, it has dropped by -$2.89 million (-42.12%). YTEN TTM CFF is now -96.79% below its all-time high of $124.03 million, reached on 31 December 2006.YTEN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -110.5% | -42.1% |
| 3 y3 years | -5.6% | -1530.0% | -74.6% |
| 5 y5 years | +5722.9% | -100.0% | +54.2% |
YTEN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -56.4% | >+9999.0% | -109.0% | at low | -74.7% | >+9999.0% |
| 5 y | 5 years | -56.4% | >+9999.0% | -102.1% | at low | -82.0% | >+9999.0% |
| alltime | all time | -94.5% | +2421.3% | -100.3% | +39.7% | -96.8% | +796.5% |
Yield10 Bioscience Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$326.00 K(-126.9%) | $3.98 M(-49.9%) |
| Mar 2024 | - | $1.21 M(>+9900.0%) | $7.94 M(+15.6%) |
| Dec 2023 | $6.87 M(<-9900.0%) | $0.00(-100.0%) | $6.87 M(0.0%) |
| Sept 2023 | - | $3.09 M(-15.0%) | $6.87 M(+82.9%) |
| June 2023 | - | $3.64 M(+2480.1%) | $3.76 M(+3083.1%) |
| Mar 2023 | - | $141.00 K(>+9900.0%) | $118.00 K(-418.9%) |
| Dec 2022 | -$37.00 K(-100.2%) | $0.00(-100.0%) | -$37.00 K(0.0%) |
| Sept 2022 | - | -$23.00 K(<-9900.0%) | -$37.00 K(+8.8%) |
| June 2022 | - | $0.00(-100.0%) | -$34.00 K(0.0%) |
| Mar 2022 | - | -$14.00 K(<-9900.0%) | -$34.00 K(-100.2%) |
| Dec 2021 | $15.75 M(+116.3%) | $0.00(-100.0%) | $15.75 M(+0.4%) |
| Sept 2021 | - | -$20.00 K(<-9900.0%) | $15.68 M(-25.5%) |
| June 2021 | - | $0.00(-100.0%) | $21.05 M(-4.8%) |
| Mar 2021 | - | $15.77 M(<-9900.0%) | $22.12 M(+203.8%) |
| Dec 2020 | $7.28 M(-48.3%) | -$62.00 K(-101.2%) | $7.28 M(-61.4%) |
| Sept 2020 | - | $5.35 M(+403.3%) | $18.84 M(+39.7%) |
| June 2020 | - | $1.06 M(+14.5%) | $13.49 M(+8.7%) |
| Mar 2020 | - | $928.00 K(-91.9%) | $12.41 M(-11.9%) |
| Dec 2019 | $14.08 M(>+9900.0%) | $11.50 M(>+9900.0%) | $14.08 M(+445.9%) |
| Sept 2019 | - | $0.00(-100.0%) | $2.58 M(0.0%) |
| June 2019 | - | -$18.00 K(-100.7%) | $2.58 M(-0.5%) |
| Mar 2019 | - | $2.60 M(>+9900.0%) | $2.59 M(+2095.8%) |
| Dec 2018 | $118.00 K(-99.2%) | $0.00(0.0%) | $118.00 K(-99.1%) |
| Sept 2018 | - | $0.00(-100.0%) | $13.44 M(-12.8%) |
| June 2018 | - | -$6000.00(-104.8%) | $15.40 M(+0.0%) |
| Mar 2018 | - | $124.00 K(-99.1%) | $15.40 M(+0.8%) |
| Dec 2017 | $15.27 M(-5259.5%) | $13.32 M(+577.4%) | $15.27 M(+690.5%) |
| Sept 2017 | - | $1.97 M(<-9900.0%) | $1.93 M(-5782.4%) |
| June 2017 | - | -$12.00 K(<-9900.0%) | -$34.00 K(-88.5%) |
| Mar 2017 | - | $0.00(-100.0%) | -$296.00 K(0.0%) |
| Dec 2016 | -$296.00 K(-102.0%) | -$22.00 K(<-9900.0%) | -$296.00 K(+8.0%) |
| Sept 2016 | - | $0.00(-100.0%) | -$274.00 K(-52.0%) |
| June 2016 | - | -$274.00 K(<-9900.0%) | -$571.00 K(-103.9%) |
| Dec 2015 | $14.70 M(-41.7%) | $0.00(-100.0%) | $14.70 M(-0.0%) |
| Sept 2015 | - | -$297.00 K(-102.0%) | $14.70 M(-63.2%) |
| June 2015 | - | $15.00 M(>+9900.0%) | $39.91 M(+58.3%) |
| Dec 2014 | $25.21 M | $1000.00(-100.0%) | $25.21 M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $24.91 M(>+9900.0%) | $25.21 M(+8304.3%) |
| June 2014 | - | $0.00(-100.0%) | $300.00 K(-2.9%) |
| Mar 2014 | - | $300.00 K(>+9900.0%) | $309.00 K(+2107.1%) |
| Dec 2013 | $14.00 K(-26.3%) | $0.00(0.0%) | $14.00 K(0.0%) |
| Sept 2013 | - | $0.00(-100.0%) | $14.00 K(0.0%) |
| June 2013 | - | $9000.00(+80.0%) | $14.00 K(+7.7%) |
| Mar 2013 | - | $5000.00(>+9900.0%) | $13.00 K(-31.6%) |
| Dec 2012 | $19.00 K(-100.0%) | $0.00(0.0%) | $19.00 K(-13.6%) |
| Sept 2012 | - | $0.00(-100.0%) | $22.00 K(+4.8%) |
| June 2012 | - | $8000.00(-27.3%) | $21.00 K(-100.0%) |
| Mar 2012 | - | $11.00 K(+266.7%) | $49.38 M(-0.1%) |
| Dec 2011 | $49.41 M(+2012.3%) | $3000.00(-400.0%) | $49.41 M(-0.0%) |
| Sept 2011 | - | -$1000.00(-100.0%) | $49.43 M(-0.3%) |
| June 2011 | - | $49.37 M(>+9900.0%) | $49.59 M(+2192.9%) |
| Mar 2011 | - | $36.00 K(+56.5%) | $2.16 M(-7.5%) |
| Dec 2010 | $2.34 M(-92.0%) | $23.00 K(-86.2%) | $2.34 M(-92.6%) |
| Sept 2010 | - | $167.00 K(-91.4%) | $31.48 M(+0.4%) |
| June 2010 | - | $1.94 M(+813.7%) | $31.36 M(+6.6%) |
| Mar 2010 | - | $212.00 K(-99.3%) | $29.43 M(+0.7%) |
| Dec 2009 | $29.23 M(+3504.7%) | $29.16 M(>+9900.0%) | $29.23 M(>+9900.0%) |
| Sept 2009 | - | $54.00 K(+5300.0%) | $98.00 K(-41.7%) |
| June 2009 | - | $1000.00(-95.0%) | $168.00 K(-75.0%) |
| Mar 2009 | - | $20.00 K(-13.0%) | $673.00 K(-17.0%) |
| Dec 2008 | $811.00 K(-68.8%) | $23.00 K(-81.5%) | $811.00 K(-36.3%) |
| Sept 2008 | - | $124.00 K(-75.5%) | $1.27 M(-19.0%) |
| June 2008 | - | $506.00 K(+220.3%) | $1.57 M(-41.6%) |
| Mar 2008 | - | $158.00 K(-67.4%) | $2.69 M(+3.6%) |
| Dec 2007 | $2.60 M(-97.9%) | $485.00 K(+14.7%) | $2.60 M(-97.6%) |
| Sept 2007 | - | $423.00 K(-74.0%) | $110.18 M(+0.9%) |
| June 2007 | - | $1.63 M(+2403.1%) | $109.22 M(+1.8%) |
| Mar 2007 | - | $65.00 K(-99.9%) | $107.26 M(-13.5%) |
| Dec 2006 | $124.03 M(+2389.5%) | $108.06 M(<-9900.0%) | $124.03 M(+677.0%) |
| Sept 2006 | - | -$541.00 K(+65.4%) | $15.96 M(-3.3%) |
| June 2006 | - | -$327.00 K(-101.9%) | $16.50 M(-1.9%) |
| Mar 2006 | - | $16.83 M | $16.83 M |
| Dec 2005 | $4.98 M(-13.5%) | - | - |
| Dec 2004 | $5.76 M | - | - |
FAQ
- What is Yield10 Bioscience annual cash flow from financing activities?
- What is the all time high annual CFF for Yield10 Bioscience?
- What is Yield10 Bioscience annual CFF year-on-year change?
- What is Yield10 Bioscience quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly CFF year-on-year change?
- What is Yield10 Bioscience TTM cash flow from financing activities?
- What is the all time high TTM CFF for Yield10 Bioscience?
- What is Yield10 Bioscience TTM CFF year-on-year change?
What is Yield10 Bioscience annual cash flow from financing activities?
The current annual CFF of YTEN is $6.87 M
What is the all time high annual CFF for Yield10 Bioscience?
Yield10 Bioscience all-time high annual cash flow from financing activities is $124.03 M
What is Yield10 Bioscience annual CFF year-on-year change?
Over the past year, YTEN annual cash flow from financing activities has changed by +$6.91 M (+18670.27%)
What is Yield10 Bioscience quarterly cash flow from financing activities?
The current quarterly CFF of YTEN is -$326.00 K
What is the all time high quarterly CFF for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly cash flow from financing activities is $108.06 M
What is Yield10 Bioscience quarterly CFF year-on-year change?
Over the past year, YTEN quarterly cash flow from financing activities has changed by -$3.42 M (-110.54%)
What is Yield10 Bioscience TTM cash flow from financing activities?
The current TTM CFF of YTEN is $3.98 M
What is the all time high TTM CFF for Yield10 Bioscience?
Yield10 Bioscience all-time high TTM cash flow from financing activities is $124.03 M
What is Yield10 Bioscience TTM CFF year-on-year change?
Over the past year, YTEN TTM cash flow from financing activities has changed by -$2.89 M (-42.12%)